1. Introduction {#sec1}
===============

Rottlerin (also called mallotoxin or kamala) is a pigmented plant product isolated from MallotusPhilippinensis ([Figure 1](#fig1){ref-type="fig"}), used in India in ancient times as a remedy for tapeworm \[[@B1]--[@B3]\].

Since 1994, Rottlerin has been used as a PKC*δ* inhibitor based on in vitro studies that have shown that the IC50 for PKC*δ* was 3--6 *μ*M compared to 30--100 *μ*M for the other PKC isozymes \[[@B4]\], although the selectivity of Rottlerin in inhibiting PKC *δ* isoform has been recently questioned \[[@B5]\].

Several phloroglucinol derivatives, which are similar to Rottlerin in structure, have been demonstrated to have antiinflammatory and antiallergic properties \[[@B6], [@B7]\].

Moreover, Rottlerin can target mitochondria, interfering in the respiratory chain as an uncoupler of oxidative phosphorylation \[[@B8]\], and activates the large conductance voltage and Ca^++^ activated K^+^ channel (BK) in human vascular smooth muscle; its use has been patented (patent WO/2006/060196) in the therapy of hypertension and related disorders \[[@B9]\].

Our laboratory showed for the first time that Rottlerin can suppress NF*κ*B activation induced by either phorbol ester or H~2~O~2~, in MCF-7 cells and in HaCaT keratinocytes, respectively, in a PKC-independent way \[[@B10], [@B11]\]. Rottlerin is a pleiotropic inhibitor, able to inhibit the activity of a number of unrelated kinases, such as AKT/PKB and calmodulin-dependent kinases (CaMKs) I-III \[[@B12], [@B13]\], two known upstream mediators of the NF*κ*B activation process \[[@B14]--[@B19]\].

Although the underlying molecular mechanisms have not been yet investigated in details Rottlerin interference in the NF*κ*B activation process was likely achieved, in MCF-7 cells, through inhibition of CaMKII, without involvement of the AKT/PKB pathway \[[@B10]\].

The transcription factor NF*κ*B consists of p50 and p65 heterodimer, which is retained in the cytoplasm by masking nuclear localization signal (NLS) by the inhibitor I*κ*B*α*. Upon activation, I*κ*B*α* kinase (IKK) phosphorylates I*κ*B*α*, promotes its ubiquitination and degradation, thus allowing p50-p65 to translocate to the nucleus, bind to its consensus sequence, and induce transcription of genes essential for cell proliferation and survival \[[@B20]\]. Consistently, Rottlerin inhibition of NF*κ*B caused downregulation of cyclin D1 and growth arrest in both MCF-7 and in HaCaT cells \[[@B10], [@B11]\].

Because NF*κ*B can be activated by a number of signaling molecules \[[@B21]\], we performed further experiments to support the idea that Rottlerin inhibits NF*κ*B in different cell types and under different stimuli.

One interesting characteristic of NF*κ*B is its extreme sensitivity to cellular redox state \[[@B22]\]. Since many agents activating NF*κ*B are modulated by Reactive Oxygen Species (ROS) or by pro-oxidants, we wondered whether the inhibitory effects of Rottlerin, previously observed by us, could be also due to its antioxidant potential. Rottlerin, indeed, is a 5,7-dihydroxy-2,2-dimethyl-6-(2,4,6-trihydroxy-3-methyl-5-acetylbenzyl)-8-cinnamoyl-l,2-chromene and contains five phenolic hydroxyl groups that might likely act as hydrogen donors in the scavenging of free radicals in analogy with other polyphenols with documented antioxidant properties. An unexhaustive list of compounds, structurally related to Rottlerin, with antioxidant activity and NF*κ*B inhibitory properties comprises Drummondins \[[@B23]\], Flavonoids \[[@B24]\], Resveratrol \[[@B25]\], Genistein \[[@B26a], [@B26b]\], Epigallocatechin-3-Gallate \[[@B27]\], and Curcumin \[[@B28]\].

Although it could have been deduced from the Rottlerin structure (known at least since 1994), only recently antioxidant properties of Rottlerin have been started to be described \[[@B29]\].

In the current paper, we demonstrate that Rottlerin has antioxidant properties and that the observed inhibitory effect on NF*κ*B might be the result of Rottlerin hydrogen donating ability and free radical scavenger activity, in addition to its biological inhibition of signaling molecules. We also provide evidence that Rottlerin inhibits NF*κ*B activation in MCF-7 and HT-29 cells and transcriptional activity in cells transfected with the NF*κ*B-driven plasmid pBIIX-LUC.

2. Materials and Methods {#sec2}
========================

2.1. Materials {#sec2.1}
--------------

Minimum Essential Medium (MEM), fetal bovine serum (FBS), antibiotics, dimethylsulfoxide (DMSO), Na-Pyruvate and L-glutamine and 1,1-Diphenyl-2-picryl-hydrazyl (DPPH), and menadione were purchased from Sigma (Milan, Italy), dihydrorhodamine 123 (DHR-123) from Invitrogen, geneticin (G418 sulfate) from Alexis (San Diego, CA), Rottlerin from Calbiochem (Milan, Italy).

2.2. Cells and Culture Conditions {#sec2.2}
---------------------------------

MCF-7 and TH-29 cells were purchased by Istituto Zooprofilattico Sperimentale della Lombardia e dell\'Emilia-Romagna, Brescia, Italy. MCF-7 cells were grown in humidified atmosphere (95% air/ 5% CO~2~) at 37°C in minimum essential medium (MEM) containing 10% FBS, Na-Pyruvate (1 mM), and antibiotics. HT-29 cells were grown in Dulbecco\'s minimum essential medium (DMEM) with 10% FBS, glutamine (2 mM), and antibiotics. After reaching subconfluence, cells were incubated in serum-free medium for 24 hr and then subjected to treatments in 2.5% FBS.

2.3. Cell Treatments {#sec2.3}
--------------------

MCF-7 and HT-29 cells, pretreated with or without 20 *μ*M Rottlerin for 30 min, were stimulated with 10 ng/mL TNF*α* for 4 hr. As to concern the vitamin E samples, 24 hr preincubation time with 50 *μ*M *α*-tocopherol (dissolved in DMSO at the final concentration in the cells of 0.1%) was selected on the basis of uptake experiments performed on cells (data not shown).

2.4. Electrophoretic Mobility Shift Assay (EMSA) {#sec2.4}
------------------------------------------------

EMSA assay was performed as previous described by Valacchi et al. 2005 \[[@B30a]\]. MCF-7 and HT-29 cells were plated on 100-mm dishes (7.5 × 10^5^ cells/dish) and treated as described above. Cells were washed three times with ice-cold PBS, and dishes placed on dry ice/ethanol. Cells were lysed in 500 *μ*l/dish buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.2 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 1 mM PMSF, 1 mM leupeptin) and transferred to microcentrifuge tubes. After incubation for 10 min on ice, Nonidet P-40 (final concentration 0.02%) was added, and suspensions were passed six times through a 26.5G needle to optimize cell lysis. Nuclei were pelleted by centrifugation for 2 min at 10,000 rpm, and supernatant (cytoplasmic extract) fractions were collected. The nuclear pellet was resuspended in 50 *μ*l of buffer B (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, 1 mM leupeptin), incubated for 30 min on ice, and centrifuged for 5 min at 10,000 rpm at 4°C to obtain clear supernatant fractions (nuclear extract). NF*κ*B consensus oligonucleotide (5′-AGT TGA GGG GAC TTT CCC AGG C-3′), NF*κ*B mutant oligonucleotide (5′-AGT TGA GGC GAC TTT CCC AGG C-3′), and NF-IL6 (consensus) (nonspecific competitor - 5′-GGAGAGATTGCCTGAC-GTCAGAGAGGCA-3′) (Santa Cruz Biotechnology) were labeled with digoxygenin (Dig) using a DIG Genius gel shift kit (Boehringer Mannheim, Indianapolis, IN, U.S.A.) and incubated overnight at 5°C with nuclear extract (20 *μ*g of protein). The complexes were electrophoresed (0.5 Tris-borate-EDTA buffer, 150 V for 2 hr at room temperature) on Novex 6% nondenaturing polyacrylamide gels (Invitrogen) and electroblotted (400 mA for 1 hr) in a sandwich procedure onto nitrocellulose (protein) and nylon (oligonucleotide) membranes. The Dig-labeled oligonucleotide was detected by anti-Dig alkaline phosphatase-conjugated Fab fragments and enhanced chemiluminescence. The p50 subunit of NF*κ*B on the nitrocellulose membrane was probed by rabbit anti-NF*κ*B (p50) antibody and detected by ECL Plus.

2.5. N,N-diphenyl-N-picrylhydrzyl (DPPH) Radical Scavenging Activity {#sec2.5}
--------------------------------------------------------------------

To evaluate the anti-oxidant activity of Rottlerin, the model of scavenging the stable free radical DPPH by hydrogen donating compounds was used.

As stock solutions, 20 *μ*M DPPH (A) and 10 *μ*M Rottlerin (B), were prepared in absolute ethanol and mixed by adding increasing volumes of the Rottlerin solution to that of DPPH in a final volume of 3 ml to obtain DPPH/Rottlerin molar ratios 10 : 1, 4 : 1, and 2 : 1. The reaction mixtures were shaken vigorously and kept in the dark for 30 min. The absorbance of the remaining DPPH was determined at 516 nm by UV/Vis Kontron 941 spectrophotometer.

For electron paramagnetic resonance (EPR) spectroscopy, the same DPPH/Rottlerin solutions were transferred to glass capillary tubes and then placed in the EPR cavity of a Varian E4 ESR spectrometer for spectral measurements.

2.6. ROS Measurement by FACS Analysis {#sec2.6}
-------------------------------------

Serum starved MCF-7 cells were pretreated with Rottlerin (5 and 20 *μ*M) for 1 hr. The cells were loaded with 10 *μ*M DHR-123 for 15 minutes, washed by Hanks\' Balanced Salt Solution (HBSS), and treated by the oxidative stress inducer, menadione (100 *μ*M), or H~2~O~2~ (100 *μ*M) for 30 min in HBSS. The reaction was stopped by cooling on ice for 1 min, and the cells were immediately analyzed by flow cytometry (BD FACSCalibur, excitation: 488 nm laser, emission: 530/30 nm). The level of ROS was indicated by median of DHR-123 fluorescence. Debris and dead cells were discriminated from the analysis using FSC versus SSC gating.

2.7. Luciferase Reporter Construct and Stable HT-29 Cell Transfection {#sec2.7}
---------------------------------------------------------------------

The reporter construct pBIIX-LUC was kindly donated by Dr. Kalle Saksela (Institute of Molecular Medicine, University of Tampere, Finland). The NF-*κ*B-driven plasmid pBIIX-LUC was constructed by inserting a synthetic fragment with two copies of the sequence ACA GAG GGG ACT TTC CGA GAG separated by four nucleotides (ATCT) in front of the mouse *fos* promoter in plasmid pfLUC \[[@B18]\].

The reporter plasmid was cotransfected with pSV2neo neomycin-resistance plasmid into HT-29 (ATCC) cells using electroporation (Bio-Rad Laboratories, Inc.; Hercules, CA). Briefly, approximately 1 × 10^7^ cells were mixed with 20 *μ*g of reporter plasmid and 2 *μ*g of pSV2neo plasmid, and electroporated (275 V, 950 *μ*F, 2x pulse). Subsequently, the cells were seeded on a 100 × 20 mm dish (TPP) with a feeder of HT-29 cells treated with mitomycin-C. Neomycin-resistant clones were selected in 300 *μ*g/mL of geneticin. The clones containing the reporter plasmid were confirmed by luciferase activity assay.

2.8. HT-29 Cell Treatment and Luciferase Activity Assay {#sec2.8}
-------------------------------------------------------

Stably transfected cells were seeded in 12-well plates and treated, 24 hr later, with Rottlerin for 30 min followed by TNF*α* (10 ng/mL) for 4 hr. After the treatment, cells were rinsed with PBS and then lysed with 100 *μ*l of reagent (Luciferase Assay System; Promega Corp., Madison, WI). Fifty *μ*l of the extracts was mixed with 50 *μ*l of luciferase substrate, and luminescence was quantified by luminometer.

2.9. Statistical Analysis {#sec2.9}
-------------------------

Results are reported as means ± SEM. Statistical analysis was performed by using Student\'s *t*-test. *P* \< .05 was considered statistically significant.

3. Results {#sec3}
==========

3.1. Rottlerin Inhibits TNF*α*-Induced NF*κ*B Binding Activity in MCF-7 and HT-29 Cells {#sec3.1}
---------------------------------------------------------------------------------------

As shown in [Figure 2](#fig2){ref-type="fig"}, nuclear extracts from nonactivated MCF-7 and HT-29 cells (C) contained a basal or constitutive NF*κ*B/DNA binding activity which was not affected by 20 *μ*M Rottlerin treatment (R) nor by Vitamin E supplementation (V). Vitamin E was chosen as control since it is a well-known liposoluble antioxidant with the ability to inhibit NF*κ*B. Treatment with 10 ng/ml TNF*α* (T) caused an elevated level of NF*κ*B/DNA binding and the pretreatment of cells with Rottlerin or Vitamin E (T+R and T+V) inhibited TNF*α*-induced NF*κ*B/DNA binding. The unlabeled NF*κ*B consensus oligomer was used as the specific competitor and unlabeled NF-IL6 consensus oligomer as the nonspecific competitor.

3.2. Antioxidant Activity of Rottlerin: Reaction with DPPH {#sec3.2}
----------------------------------------------------------

In the case of the UV measurements, the DPPH and Rottlerin spectra do not overlap and the complete disappearance of the typical absorption of DPPH at 514 nm was observed when equal volume of the DPPH and Rottlerin solutions, A and B, respectively, were mixed ([Figure 3](#fig3){ref-type="fig"}). Similar results were obtained by EPR, which directly measures the free radical concentration; by mixing the two solutions into the EPR cavity, the typical EPR signal of DPPH disappeared when equal volumes of the reagents solutions were mixed, that is in a 2 : 1 molar ratio (Figur  4), because two molecules of DPPH are reduced by one molecule of Rottlerin.

3.3. ROS Scavenging Activity of Rottlerin {#sec3.3}
-----------------------------------------

As shown in [Figure 5](#fig5){ref-type="fig"}, both 5 and 20 *μ*M Rottlerin significantly decreases MCF-7 basal ROS levels and largely prevent ROS generated by a 30-min treatment with either 100 *μ*M H~2~O~2~ or 100 *μ*M menadione.

3.4. Effect of Rottlerin on NF*κ*B Activation in HT-29 Transfected Cells {#sec3.4}
------------------------------------------------------------------------

As shown in [Figure 6](#fig6){ref-type="fig"}, Rottlerin pretreatment for 30 min prevented activation of NF*κ*B in a dose-dependent manner, both basal and after a 4 hr TNF*α* treatment in HT-29 cells transfected with the NF*κ*B-driven plasmid pBIIX-LUC.

These results confirm that Rottlerin is a general inhibitor of NF*κ*B nuclear migration and transcriptional activity*.*

4. Discussion {#sec4}
=============

DPPH is a stable free radical, which is widely used to test the hydrogen donation of antioxidants \[[@B31]\]. Recently, the ability of Rottlerin to scavenge DPPH in comparison to other phenolic phytochemicals has been described. Empirically established concentrations of phytochemicals and DPPH showed that the Rottlerin scavenging ability was lower than that of resveratrol and genistein, higher than that of quercetin and epigallocatechin gallate, and roughly of the same order of that of curcumin \[[@B29]\].

In the present study, in order to further evaluate the hydrogen donation power of Rottlerin, we reacted one molecule of Rottlerin with two molecules of DPPH and followed the reaction by UV measurement and EPR spectroscopy (Figures [2](#fig2){ref-type="fig"}and [3](#fig3){ref-type="fig"}). This last reaction is thermodynamically supported by the fact that the Bond Dissociation Enthalpy of the N-H group of the reduced DPPH is 80 Kcal/mol \[[@B32]\] and that of the O-H group of Vit-E is 77.9 Kcal/mol \[[@B33]\]. On the basis of this data it may be assumed that the hydrogen donation power of Rottlerin is of the same order of that of Vit-E, which is recognized like the best antioxidant for lipid systems \[[@B34]\].

The radical scavenging ability of polyphenols depends mainly on the positioning of the O-H groups rather than on their number \[[@B35]\], and this could be evident in Rottlerin, which possesses five phenolic O-H all conjugated to the same −CH~2~− group. This may suggest a higher antioxidant activity than that of the two frequently used ROS scavengers, namely, butylated hydroxyanisole (BHA) and butylatedhydroxytoluene (BHT), which show BDEs of 81.1 and 79.1 Kcal/mol, respectively \[[@B36]\].

Because DPPH is an artificial radical and may not reproduce the in vivo situation, we also tested the Rottlerin antioxidant properties on cultured cells. According to the DPPH radical-reducing activity and its fast reactivity, Rottlerin neutralized hydrogen peroxide added to the cells and prevents free radicals generation ([Figure 4](#fig4){ref-type="fig"}). These finding are consistent with our previous report showing that Rottlerin quickly inhibited NF*κ*B activation triggered by hydrogen peroxide in HaCaT keratinocytes \[[@B11]\] and are in accordance with the study by Longpre and Loo \[[@B29]\], showing that 20 *μ*M Rottlerin prevented deoxycholate-induced ROS generation in HCT-116 cells.

Rottlerin-mediated inhibition of NF*κ*B is not restricted to PMA \[[@B10]\] and hydrogen peroxide \[[@B11]\] because it also blunts TNF*α*-mediated NF*κ*B activation. The current study indeed showed that NF*κ*B nuclear migration and transcriptional activity, both basal and after stimulation by TNF*α*, are strongly inhibited by the drug in native MCF-7 cells and in HT-29 cells, and in HT-29 transfected with the NF*κ*B-driven plasmid pBIIX-LUC, (2). Our results also parallel with a study by Zhang et al. where has been shown that Rottlerin inhibits NF*κ*B activation in MCF7 sensitized cells to TRAIL-induced apoptosis \[[@B37]\].

Taking in account the current results and previous data on PMA-stimulated MCF-7 cells \[[@B10]\] and H~2~O~2~-stimulated-HaCaT cells \[[@B11]\], it can be safely stated that Rottlerin is a general inhibitor of NF*κ*B regardless of the activation pathway (PMA, oxidative stress or TNF*α*) and the cell type (MCF-7, HaCaT, HT-29 cells).

By integrating these findings, we conclude that the inhibitory effect of Rottlerin on NF*κ*B is likely the result of a convergent double activity, free radical scavenging, and inhibition of key molecules, such as CaMKII \[[@B10]\] and/or PKC \[[@B38], [@B39]\] involved in the NF*κ*B activation process.

Activation of NF*κ*B is regulated by a bewildering number of signaling pathways, the contribution of which, in particular the cascade that mediates oxidative stress-induced NF*κ*B, is not always known in detail. The only target common to the several positive or negative signals to NF*κ*B is the IKK complex, but this, representing the final converging step of the different cascades, does not give information on the upstream mediators.

It is likely that Rottlerin acts at a step in which all the stimuli used (PMA, H~2~O~2~, menadione, TNF*α*) converge in the signal transduction pathway leading to NF*κ*B activation.

It has been reported that 100 *μ*M Resveratrol blocks NF*κ*B activation through inhibition of the upstream PKC *δ*/PKD cascade in HeLa cells \[[@B39]\]. Since Rottlerin, at doses between 5 and 20 *μ*M, is a PKC*δ* inhibitor, we initially thought that the Resveratrol\'s mechanism of action could explain also the Rottlerin effects on NF*κ*B in MCF-7 cells. However, a preliminary experiment showed that 20 *μ*M Rottlerin did not inhibit PMA-stimulated PKD phosphorylation on Ser 744 and Ser 748 (unpublished observation), indicating that Resveratrol and Rottlerin, although both are antioxidant with similar potency \[[@B29]\] and PKC *δ* inhibitors, act with different mechanisms in NF*κ*B inhibition.

As far as the Rottlerin antioxidant effect is concerned, the interference of other natural antioxidants in the NF*κ*B activation process has been already described. For example, mangiferin, a natural polyphenol with antioxidant properties, and melatonin, another potent antioxidant, block TNF-induced NF*κ*B activation \[[@B40], [@B41]\].

In closing, the antioxidant effect of Rottlerin surely plays a main role in the NF*κ*B activation process triggered by PMA or H~2~O~2~ or menadione or TNF*α*, but further studies will be necessary to establish the relative contribution of the two (chemical and biological) mechanisms and to clarify whether they act in parallel or in interdependent ways.
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![Chemical structure of Rottlerin.](JBB2009-742936.001){#fig1}

![Rottlerin inhibits TNF*α*-induced NF-*κ*B/DNA binding activities in MCF-7 and HT-29 cells. Cells were pretreated with Rottlerin (20 *μ*M) or with Vitamin E (50 *μ*M) with subsequent stimulation with TNF*α* (10 ng/mL) for 4 hr. Nuclear extracts (20 *μ*g) were used to determine NF-B DNA binding activities by electrophoretic mobility shift assay (EMSA) using DIG-labled oligonucleotide containing NF*κ*B element. The unlabeled NF*κ*B consensus oligomer was used as the specific competitor and unlabeled NF-L6 consensus oligomer as the nonspecific competitor. Bottom panel shows the bands quantification of a representative blot. Complexes were visualized by chemiluminescence. Lanes: C, control; R, Rottlerin; T, TNF*α*; R+T; Rottlerin and TNF*α*; V, Vitamin E; V+T, Vitamin E and TNF*α*.](JBB2009-742936.002){#fig2}

![UV spectra of DPPH/Rottlerin solutions in absolute ethanol. (a) 20 *μ*M DPPH ethanol solution (A); (b) spectrum of the mixture DPPH/Rottlerin obtained by mixing 2.5 ml of solution A with 0.5 ml of solution B (10 : 1 molar ratio); (c) 2.0 ml of solution A with 1 ml of solution B (4 : 1 molar ratio); (d) 1.5 ml of solution A with 1.5 ml of solution B (2 : 1 molar ratio); (e) spectrum of 10 *μ*M Rottlerin ethanol solution (B).](JBB2009-742936.003){#fig3}

![EPR spectra of DPPH /Rottlerin solutions in absolute ethanol. (a) 20 *μ*M DPPH ethanol solution (A); (b), (c), and (d) correspond to the (b), (c), and (d) solutions of [Figure 2](#fig2){ref-type="fig"}. All spectra were recorded in the same experimental conditions.](JBB2009-742936.004){#fig4}

![Rottlerin prevents both basal and induced intracellular production of H~2~O~2~. MCF-7 cells were pretreated with 5 and 20 *μ*M Rottlerin for 1 hr and loaded by H~2~O~2~-specific fluorescent probe DHR-123. Cells were treated with menadione (100 *μ*M) and hydrogen peroxide (100 *μ*M) for 30 min and analyzed using flow cytometry.](JBB2009-742936.005){#fig5}

![Effect of Rottlerin on NF*κ*B nuclear translocation and transcriptional activity in HT-29 transfected cells. HT-29 cells, stably transfected with the NF*κ*B-driven plasmid pBIIX-LUC, were pretreated for 30 min with 5 and 20 *μ*M Rottlerin and then treated with 10 ng/mL TNF*α* for 4 hr, before luciferase activity measurement. Data are the mean value ± SD of four independent experiments.](JBB2009-742936.006){#fig6}
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